Stockreport

Novo Nordisk to slash Ozempic and Wegovy list prices by up to 50% for 2027 [CNN]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF loss drug Wegovy and diabetes drugs Ozempic and Rybelsus by up to half starting in 2027. The $675 monthly list price is aimed at making the GLP-1 medications more acce [Read more]